Cell-Based Therapy Shows Promise In Patients With Parkinson’s Disease

A novel cell therapy using retinal pigment epithelial (RPE) cells attached to tiny gelatin bead microcarriers implanted in the brain can improve the symptoms of patients with moderate to advanced Parkinson’s disease (PD).Rush University Medical Center neurosurgeon Dr. Roy A. E.

More: continued here

Filed under: Parkinson's Disease on May 15th, 2008